Leonardo Viana Nicacio
CIK: 0002064901
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Nicacio Leonardo Viana
Nicacio Leonardo Viana (SEC CIK 0002064901) files insider reports with the SEC as Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Chief Medical Officer of Protara Therapeutics, Inc. (TARA).
Signal8 holds 5 ownership filings by Nicacio Leonardo Viana (2 Form 3, 3 Form 4), filed between Apr 17, 2025 and Aug 17, 2026. Those filings report 3 transactions, from Apr 15, 2025 to Aug 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nicacio Leonardo Viana's filings is in NORWOOD, MA.
Recent filings by Nicacio Leonardo Viana
Other insiders filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP)
- Cormorant Asset Management, LP, Officer
- Ben Yong, Director
- Saxena Nishant C, Chief Business Officer
- Cohen Yuval, Chief Executive Officer
- Moran Sean F., Chief Financial Officer
- Kung Winston, Director